Related Experiment Video

Updated: Jul 13, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Differences in management and outcome of ischemic and non-ischemic cardiomyopathy

Austin Chin Chwan Ng1, Andrew Paul Sindone, Helen Siu Ping Wong

  • 1Concord RG Hospital, Department of Cardiology, Hospital Road, Concord 2139 NSW Australia.

International Journal of Cardiology
|August 21, 2007
PubMed

Insights

Mortality in heart failure patients with cardiomyopathy is high. Kidney function (serum creatinine) is a key predictor of death, especially in ischemic cardiomyopathy, while non-ischemic patients showed better long-term recovery.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Outcomes

Background:

  • Ischemic cardiomyopathy (ICM) and non-ischemic cardiomyopathy (NICM) are distinct causes of heart failure.
  • Understanding differences in management and outcomes between ICM and NICM is crucial.

Purpose of the Study:

  • To compare the clinical characteristics, management, and long-term outcomes of patients with ICM and NICM.
  • To identify predictors of mortality in cardiomyopathy patients.

Main Methods:

  • A cohort study of 168 consecutive heart failure patients (90 ICM, 78 NICM).
  • Follow-up duration of approximately 40 months.
  • Analysis of baseline characteristics, medication use, left ventricular ejection fraction (LVEF), and mortality.

Main Results:

  • ICM patients were older with worse functional status but similar baseline LVEF compared to NICM.
  • Both groups showed significant LVEF improvement over time and high rates of guideline-directed medical therapy.
  • Overall 40-month mortality was 17%; elevated serum creatinine (>120 micromol/L) was a significant independent predictor of death (RR 2.9).

Conclusions:

  • Cardiomyopathy mortality remains substantial and is strongly linked to renal function (serum creatinine).
  • Non-ischemic cardiomyopathy patients demonstrated better long-term improvement in symptoms and cardiac function.
  • Serum creatinine is a critical prognostic marker in heart failure patients.
Abstract

More Related Videos

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...